Akron's obesity gradient against Summit County and Ohio, the standing Medicaid obesity-drug exclusion, the Fairlawn-versus-city price split, and six freshly designated neighborhood shortage areas.
42.7% of Akron adults have obesity (crude prevalence, BRFSS 2023, CDC PLACES 2025 release, Akron city geography) 1. The gradient is the point: Akron runs about five points above its own county, Summit at 37.6% 2, and about six above Ohio statewide at 36.4% 3.
This is a city of 189,664 inside a metro of 702,209 45, with a median household income of $48,521 and 8.8% of residents uninsured (ACS 2024 1-year) 6. For roughly four in ten Akron adults, the question is not whether treatment exists but what it costs out of pocket, because coverage is not coming from Medicaid.
Ohio Medicaid does not cover GLP-1s for weight loss. Ohio Administrative Code 5160-9-03(B)(1), effective Feb 16, 2024 and still in force, categorically excludes drugs for the treatment of obesity from pharmacy coverage 12, and the state's Unified Preferred Drug List effective April 1, 2026 lists Zepbound nowhere; Wegovy appears only under prior-authorization pathways for non-obesity indications, cardiovascular risk reduction and MASH, so it is not available for weight loss alone 13.
GLP-1s are covered for type 2 diabetes with prior authorization and step-therapy requirements. The UPDL applies to both fee-for-service and Ohio's Next Generation managed-care plans, so the exclusion holds across plans 13. Ohio is not among the 13 state Medicaid programs KFF counts as covering GLP-1s for obesity as of January 2026, a list that shrank from 16 in October 2025 15, and glpchart.com's Ohio row, updated July 20, 2026, matches 14.
Akron's GLP-1 money map is split along the city line. Inside city limits, Personalized Vitality Clinic on Merriman Road headlines a compounded GLP-1 program at $30/shot and states its compounded GLP-1s come from licensed compounding pharmacies, but publishes no monthly total: full plan pricing requires booking a complimentary discovery call, and that $30 is the only dollar amount on the page and the only per-unit number published by a clinic inside Akron (checked Aug 27, 2026) 8. ReLux Medical Spa, checked the same day, publishes no prices at all 11.
The full published prices sit in suburban Fairlawn. Fairlawn Aesthetic MD advertises its semaglutide prescription weight loss program at $399/month, stating the price is all-inclusive of physician visits, the medication, and supplies with weekly at-home injections, under a Serving Summit County banner 9. Plastic Surgeons of Akron, also in Fairlawn, publishes $600 to $750 per vial with initial bloodwork and follow-up appointments included, noting most patients use one vial per month, for compounded semaglutide and compounded tirzepatide 10.
Astra's price is national and flat: $68/month for semaglutide and $118/month for tirzepatide on 12-month plans, $816 and $1,416 per year, billed annually, the same in every city and at every dose. There is no Akron-specific price or local offer.
Akron has unusually strong institutional weight-management anchors for a tier-2 metro. Summa Health's Weight Management Institute on its Akron campus runs a medical weight loss program in which every patient starts with a board-certified obesity medicine provider assessment, with weight-loss medications prescribed as indicated, staffed by board-certified obesity medicine physicians, behavioral health specialists and dietitians 16. Cleveland Clinic Akron General offers bariatric surgery and weight management in-city, with Cleveland Clinic's main-campus Bariatric & Metabolic Institute about 40 miles north 17. The gap is not specialist existence but throughput and price: these are referral and consult programs, not transparent cash-pay GLP-1 channels, and no Akron hospital program publishes a GLP-1 cash price.
Per HRSA's Primary Care HPSA designation file (accessed Aug 27, 2026), Summit County carries nine active primary-care shortage designations, and seven were newly designated in 2025: six Low Income Population HPSAs covering Akron's core neighborhoods, East Akron (score 19, population 13,128), Kenmore/Summit Lake (19; 12,261), University Park/Goodyear (19; 14,347), North Hill/Chapel Hill/Merriman (17; 15,495), West Akron (17; 13,351), and South Akron (13; 10,018), plus LI-Barberton (19; 6,172) next door. The six Akron-neighborhood designations together cover roughly 78,600 residents, and two facility HPSAs add to the picture, Asian Services In Action Inc (score 20) and Community Support Services Inc (score 19). HRSA re-drew and designated these areas between April and July 2025, so the federal government's newest data says much of Akron's urban core is underserved for primary care right now 7.
What telehealth answers here is the throughput-and-transparency gap, not a specialist-existence gap: a published price, an Ohio-licensed clinician by video, and no consult-first funnel to reach a number. The Ohio GLP-1 overview covers statewide rules.
Astra treats patients in Ohio through state-licensed physicians.
Published cash prices around Akron run $399 to roughly $750 a month — and both full prices sit in suburban Fairlawn, not the city. Fairlawn Aesthetic MD advertises a $399/month all-inclusive semaglutide program (visits, medication, supplies; checked Aug 27, 2026). Plastic Surgeons of Akron publishes $600–$750 per vial for compounded semaglutide or tirzepatide, with most patients using one vial per month. Inside city limits, Personalized Vitality Clinic headlines "$30/shot" but publishes no monthly total. Astra's price is the same in Akron as everywhere else: $68/month for semaglutide on a 12-month plan ($816 billed annually).
No. Ohio Administrative Code 5160-9-03 categorically excludes drugs for the treatment of obesity from Medicaid pharmacy coverage, and Zepbound appears nowhere on the state's Unified Preferred Drug List effective April 1, 2026. Wegovy is coverable only through prior-authorization pathways for non-obesity indications (cardiovascular risk reduction and MASH) — not for weight loss alone. GLP-1s are covered for type 2 diabetes with prior authorization and step-therapy requirements, and the exclusion applies across fee-for-service and Ohio's Next Generation managed-care plans. Ohio is not among the 13 state Medicaid programs KFF counted as covering GLP-1s for obesity in January 2026.
As of August 27, 2026, the full program prices sit outside city limits: Fairlawn Aesthetic MD ($399/month semaglutide program) and Plastic Surgeons of Akron ($600–$750 per vial, compounded semaglutide or tirzepatide), both in Fairlawn. Inside Akron proper, Personalized Vitality Clinic publishes only a "$30/shot" headline with the full plan price behind a discovery call, and ReLux Medical Spa advertises semaglutide and tirzepatide with no prices at all. Astra publishes one national price: $68/month semaglutide, $118/month tirzepatide, on 12-month plans.
Both run institutional weight-management programs in Akron. Summa Health's Weight Management Institute starts every medical weight loss patient with a board-certified obesity medicine provider assessment and prescribes weight-loss medications as indicated. Cleveland Clinic Akron General offers bariatric surgery and weight management in-city. These are consult-based programs — you enter through an appointment or referral, not a price menu — and neither publishes a cash GLP-1 price.
Against every published Akron-area price, yes. Astra's $68/month semaglutide (12-month plan, $816 billed annually) is $331/month less than Fairlawn Aesthetic MD's $399 program, and Astra's $118/month tirzepatide ($1,416 billed annually) compares with $600–$750 per vial at Plastic Surgeons of Akron. But it is not an Akron discount — Astra charges the same national price in every city and at every dose. The only in-city published number, Personalized Vitality's $30/shot, has no published monthly total to compare against.
Last reviewed:
Educational information, not medical advice. Treatment requires evaluation by a licensed physician.